Efficacy of pegylated interferon-alpha-2a plus ribavirin for patients aged at least 60 years with chronic hepatitis C
Chinese Medical Journal, 06/12/2012Yingying Z et al. –
Among patients with hepatitis C virus genotype 1, the elderly patients had lower sustained virological response than non–elderly patients during pegylated interferon–alpha–2a plus ribavirin combination therapy.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.